Literature DB >> 32419206

Hijacking the NLRP3 inflammasome: a mechanism underlying viral respiratory disease?

Zhirong Zhang1,2,3,4, Romeo Ricci1,2,3,4,5.   

Abstract

In contrast to highly specific sensor molecules of the innate immune system, the NLRP3 receptor detects a broad variety of danger signals including pathogens. Sensing triggers intracellular NLRP3 inflammasome complex assembly to induce an inflammatory response with the primary aim to eliminate pathogens. However, several of them have developed distinct strategies to hijack NLRP3-dependent immunity. In this issue of EMBO Reports, Zhang and colleagues demonstrate that reovirus infection of airway epithelial cells promotes EphA2-dependent phosphorylation of NLRP3 that impedes the recruitment of other inflammasome components necessary for its activation [1]. This potentially uncovers a mechanism that may lead to reduced viral clearance in the lung, eventually contributing to life-threatening respiratory disease.
© 2020 The Authors.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32419206      PMCID: PMC7332972          DOI: 10.15252/embr.202050645

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  11 in total

1.  Critical role for calcium mobilization in activation of the NLRP3 inflammasome.

Authors:  Tomohiko Murakami; Johan Ockinger; Jiujiu Yu; Vanessa Byles; Aisleen McColl; Aldebaran M Hofer; Tiffany Horng
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-25       Impact factor: 11.205

Review 2.  Modulation of inflammasome pathways by bacterial and viral pathogens.

Authors:  Mohamed Lamkanfi; Vishva M Dixit
Journal:  J Immunol       Date:  2011-07-15       Impact factor: 5.422

3.  K⁺ efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter.

Authors:  Raúl Muñoz-Planillo; Peter Kuffa; Giovanny Martínez-Colón; Brenna L Smith; Thekkelnaycke M Rajendiran; Gabriel Núñez
Journal:  Immunity       Date:  2013-06-27       Impact factor: 31.745

4.  A role for mitochondria in NLRP3 inflammasome activation.

Authors:  Rongbin Zhou; Amir S Yazdi; Philippe Menu; Jürg Tschopp
Journal:  Nature       Date:  2010-12-01       Impact factor: 49.962

5.  Hijacking the NLRP3 inflammasome: a mechanism underlying viral respiratory disease?

Authors:  Zhirong Zhang; Romeo Ricci
Journal:  EMBO Rep       Date:  2020-05-17       Impact factor: 8.807

Review 6.  Inflammasomes: Threat-Assessment Organelles of the Innate Immune System.

Authors:  Charles L Evavold; Jonathan C Kagan
Journal:  Immunity       Date:  2019-08-28       Impact factor: 31.745

7.  Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization.

Authors:  Veit Hornung; Franz Bauernfeind; Annett Halle; Eivind O Samstad; Hajime Kono; Kenneth L Rock; Katherine A Fitzgerald; Eicke Latz
Journal:  Nat Immunol       Date:  2008-07-11       Impact factor: 25.606

8.  EphA2 phosphorylates NLRP3 and inhibits inflammasomes in airway epithelial cells.

Authors:  Ao Zhang; Junji Xing; Tianliang Xia; Hua Zhang; Mingli Fang; Shibing Li; Yong Du; Xian C Li; Zhiqiang Zhang; Mu-Sheng Zeng
Journal:  EMBO Rep       Date:  2020-04-30       Impact factor: 8.807

9.  Protein kinase D at the Golgi controls NLRP3 inflammasome activation.

Authors:  Zhirong Zhang; Gergö Meszaros; Wan-Ting He; Yanfang Xu; Helena de Fatima Magliarelli; Laurent Mailly; Michael Mihlan; Yansheng Liu; Marta Puig Gámez; Alexander Goginashvili; Adrien Pasquier; Olga Bielska; Bénédicte Neven; Pierre Quartier; Rudolf Aebersold; Thomas F Baumert; Philippe Georgel; Jiahuai Han; Romeo Ricci
Journal:  J Exp Med       Date:  2017-07-17       Impact factor: 17.579

10.  PtdIns4P on dispersed trans-Golgi network mediates NLRP3 inflammasome activation.

Authors:  Jueqi Chen; Zhijian J Chen
Journal:  Nature       Date:  2018-11-28       Impact factor: 69.504

View more
  1 in total

1.  Hijacking the NLRP3 inflammasome: a mechanism underlying viral respiratory disease?

Authors:  Zhirong Zhang; Romeo Ricci
Journal:  EMBO Rep       Date:  2020-05-17       Impact factor: 8.807

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.